EMD-48210
SARS-CoV-2 Wuhan Spike ectodomain in complex with NHP polyclonal antibody NVX-NHPSA5 (NVX-CoV2373/rS-Beta immunized)
EMD-48210
Single-particle4.5 Å
Deposition: 06/12/2024Map released: 15/01/2025
Last modified: 15/01/2025
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Wuhan spike ectodomain in complex with NHP polyclonal antibody NVX-NHPSA5
Deposition Authors: Ward AB
,
Bangaru S ,
Jackson AM
Sample: SARS-CoV-2 Wuhan spike ectodomain in complex with NHP polyclonal antibody NVX-NHPSA5
Deposition Authors: Ward AB
,
Bangaru S ,
Jackson AM
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines.
Bangaru S ,
Jackson AM ,
Copps J ,
Fernandez-Quintero ML,
Torres JL ,
Richey ST ,
Nogal B ,
Sewall LM ,
de la Pena AT ,
Rehman A ,
Guebre-Xabier M,
Girard B ,
Das R,
Corbett-Helaire KS ,
Seder RA,
Graham BS ,
Edwards DK ,
Patel N,
Smith G ,
Ward AB
(2024) bioRxiv
,
Jackson AM ,
Copps J ,
Fernandez-Quintero ML,
Torres JL ,
Richey ST ,
Nogal B ,
Sewall LM ,
de la Pena AT ,
Rehman A ,
Guebre-Xabier M,
Girard B ,
Das R,
Corbett-Helaire KS ,
Seder RA,
Graham BS ,
Edwards DK ,
Patel N,
Smith G ,
Ward AB
(2024) bioRxiv
Grant Support:
- Bill & Melinda Gates Foundation: OPP1170236 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): UM1 AI144462 (United States)